Stock LTUS LOTUS PHARM
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News LOTUS PHARM OTC Bulletin Board

Equities

LTUS

US5457151042

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for LOTUS PHARM
2023 Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries MT
2021 Thai oil firm PTT expands pharma business with $475 million Alvogen deal RE

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lotus Pharmaceuticals announces the acquisition of Teva Pharma Thailand, expanding its footprint in Southeast Asia
AQ
Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth
AQ
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
AQ
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
AQ
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA
AQ
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries
MT
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia
AQ
Lotus revenues grow by 16% and profit doubles year over year
AQ
Lotus acquires Alimta in Taiwan from Lilly
AQ
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders
AQ
Lotus Reports Solid Performance in First Quarter of 2022
AQ
Lotus Pharmaceuticals : Unaudited Financial Statement
PU
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly
AQ
Lotus achieves another record high EPS for FY2021
AQ
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal
AQ
Thai oil firm PTT expands pharma business with $475 million Alvogen deal
RE
Lotus Pharmaceuticals : Informational Disclosure
PU
Lotus Pharmaceuticals : Unaudited Financial Statements
PU
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund
RE
Lotus Pharmaceuticals : PTT invests in Lotus
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LTUS Stock
  4. LTUS Stock
  5. News LOTUS PHARM